| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Stuart Bryan is a See Remarks at Fulcrum Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 2 sells.
Estimated insider holdings value: $198K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2021 | FULC Fulcrum Therapeutics, Inc. | See Remarks | Sale+OE | 60,000 | $20.42 | $1,225,000.00 | -100% | -3.6% | -62.5% |